Amanda (Wooster) McCormick
Immunotherapeutics & Biotechnology
 |
|
Biography
Amanda (Wooster) McCormick completed both her Bachelor of Science (BS) degree in Animal Science and her Bachelor of Arts (BA) degree in Biochemistry from Abilene Christian University, Abilene, Texas in 2016. She worked from 2016-2019 as a Research Technician in the lab of Dr. Devin Lowe with our Abilene campus, and then joined the Graduate Program in Pharmaceutical Sciences as a Doctor of Philosophy (PhD) student in August of 2019. Amanda is presently still working in the laboratory of Dr. Devin Lowe with the Department of Immunotherapeutics and Biotechnology in Abilene.
Education:
- BS: Animal Science, Abilene Christian University, Abilene, Texas, 2016
- BA: Biochemistry, Abilene Christian University, Abilene, Texas, 2016
Research Interests:
Dendritic-cell vaccines, T-cell activation, tumor angiogenesis
Publications:
Before Admission to GPPS:
- Wooster AL, Anderson TS, Lowe DB. Expression and characterization of soluble epitope-defined major histocompatibility complex (MHC) from stable eukaryotic cell lines. J Immunol Methods. 2019 Jan;464:22-30. Epub 2018 Oct 19.
- Devin B Lowe, Camille K Bivens, Alexis S Mobley, Christian E Herrera, Amanda L McCormick, Timea Wichner, Manoj K Sabnani, Laurence M Wood & Jon A Weidanz. TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets. MAbs. May/Jun 2017; 9(4):603-614.
After Admission to GPPS:
- Anderson TS, Wooster AL, Piersall SL, Okpalanwaka IF, Lowe DB. Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity. Semin Cancer Biol. 2022 Nov; 86(Pt 3):981-996. Epub 2022 Feb 8.
- Anderson TS, Wooster AL, La-Beck NM, Saha D, Lowe DB. Antibody-drug conjugates: an evolving approach for melanoma treatment. Melanoma Res. 2021 Feb 1;31(1):1-17.
- Wooster AL, Girgis LH, Brazeale H, Anderson TS, Wood LM, Lowe DB. Dendritic cell vaccine therapy for colorectal cancer. Pharmacol Res. 2021 Feb;164:105374. Epub 2020 Dec 28.
- Anderson TS, Wooster AL, La-Beck NM, Saha D, Lowe DB. Antibody-drug conjugates: an evolving approach for melanoma treatment. Melanoma Res. 2020 Nov 6. Online ahead of print.
Presentations:
- Wooster AL, Anderson TS, Piersall SL, Lowe DB. "Analysis of the effects of therapeutic vaccination with tumor vascular-primed dendritic cells in a mouse model of colon cancer". American Association for Cancer Research (AACR) Special Conference, Boston, MA; October 2022.
- Amanda L. Wooster, Trevor S. Anderson, Savanna L. Piersall, Devin B. Lowe. "Analysis of the Effects of Therapeutic Vaccination with Tumor Vascular-Primed Dendritic Cells in a Mouse Model of Colon Cancer". 19th Annual Research Days, Ìð¹ÏÊÓƵ Jerry H Hodge School of Pharmacy, Office of Sciences in Amarillo, event at Lubbock, TX; June 2022.
Seminars:
- 03/24/2023 "Analysis of the effects of therapeutic vaccination with tumor vascular-primed dendritic cells in a mouse model of colon cancer"
- 12/03/2021 “Therapeutic targeting of CD163+ macrophages in colorectal cancer with a novel bispecific antibody" [Oral Qualifying Exam, public presentation counted as Seminar credit]
- 04/23/2021 "Production and assessment of a novel bifunctional protein targeting the tumor vasculature in solid cancers"
Awards/Scholarships:
- Kent R. Hance Endowed Scholarship, Ìð¹ÏÊÓƵ, April 2020.
Memberships:
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ìð¹ÏÊÓƵ – Vice-President, 2022-2023.
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ìð¹ÏÊÓƵ – Vice-President, 2021-2022.
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ìð¹ÏÊÓƵ – Vice-President/President-Elect, 2020-2021.
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ìð¹ÏÊÓƵ – Secretary, 2019.
- Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA), Ìð¹ÏÊÓƵ, 2019-present.